Jury in New Jersey Finds That Risperdal Not a Factor in Man’s Diabetes

Bloomberg reports that a jury in New Jersey has found in favor of Risperdal manufacturer Johnson & Johnson and determined that the anti-psychotic drug was not a substantial factor in the man’s developing diabetes.